StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30511% above fair value
$195.00−4.33 (-2.17%)

Close on Nov 20, 2026Market cap $77.85BP/E –Yield –

Moderna shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Moderna's shares outstanding was 398M at Jun 30, 2026. For fiscal 2025 it was 389M, up 1.3% from the year before. The highest annual figure on record is 431M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025389M+1.3%
FY2024Dec 31, 2024384M+0.5%
FY2023Dec 31, 2023382M-8.2%
FY2022Dec 31, 2022416M-3.5%
FY2021Dec 31, 2021431M+13.1%
FY2020Dec 31, 2020381M+15.1%
FY2019Dec 31, 2019331M+308.1%
FY2018Dec 31, 201881M+25.8%
FY2017Dec 31, 201764M+6.2%
FY2016Dec 31, 201661M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026398M+2.6%
Q1 FY2026Mar 31, 2026395M+2.3%
Q4 FY2025Dec 31, 2025392M+1.3%
Q3 FY2025Sep 30, 2025390M-2.3%
Q2 FY2025Jun 30, 2025388M+1.0%
Q1 FY2025Mar 31, 2025386M+1.0%
Q4 FY2024Dec 31, 2024387M+1.3%
Q3 FY2024Sep 30, 2024399M+4.7%
Q2 FY2024Jun 30, 2024384M+0.8%
Q1 FY2024Mar 31, 2024382M-5.7%
Q4 FY2023Dec 31, 2023382M-6.1%
Q3 FY2023Sep 30, 2023381M-7.5%
Q2 FY2023Jun 30, 2023381M-9.1%
Q1 FY2023Mar 31, 2023405M-4.9%
Q4 FY2022Dec 31, 2022407M-5.6%
Q3 FY2022Sep 30, 2022412M-5.1%
Q2 FY2022Jun 30, 2022419M-2.8%
Q1 FY2022Mar 31, 2022426M-0.9%
Q4 FY2021Dec 31, 2021431M+8.8%
Q3 FY2021Sep 30, 2021434M+9.9%
Q2 FY2021Jun 30, 2021431M+13.1%
Q1 FY2021Mar 31, 2021430M+21.8%
Q4 FY2020Dec 31, 2020396M+18.1%
Q3 FY2020Sep 30, 2020395M+19.4%
Q2 FY2020Jun 30, 2020381M+15.7%
Q1 FY2020Mar 31, 2020353M+7.4%
Q4 FY2019Dec 31, 2019335M+164.4%
Q3 FY2019Sep 30, 2019331M+399.0%
Q2 FY2019Jun 30, 2019329M+399.2%
Q1 FY2019Mar 31, 2019329M+402.5%
Q4 FY2018Dec 31, 2018127M–
Q3 FY2018Sep 30, 201866M–
Q2 FY2018Jun 30, 201866M–
Q1 FY2018Mar 31, 201865M–

More Moderna figures

See a number that looks wrong?